Taro Pharmaceutical Industries Stock Technical Analysis
TARO Stock | USD 42.51 0.12 0.28% |
As of the 3rd of May, Taro Pharmaceutical has the Risk Adjusted Performance of (0.02), coefficient of variation of (3,273), and Variance of 0.3285. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Taro Pharmaceutical, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Taro Pharmaceutical Industries, which can be compared to its competition. Please validate Taro Pharmaceutical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Taro Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 42.51 per share. Given that Taro Pharmaceutical has information ratio of (0.13), we advise you to double-check Taro Pharmaceutical Industries's current market performance to make sure the company can sustain itself at a future point.
Taro Pharmaceutical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Taro, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TaroTaro |
Taro Pharmaceutical Analyst Consensus
Target Price | Advice | # of Analysts | |
35.0 | Hold | 1 | Odds |
Most Taro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Taro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Taro Pharmaceutical, talking to its executives and customers, or listening to Taro conference calls.
Taro Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Taro Pharmaceutical Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Taro Pharmaceutical volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Taro Pharmaceutical Trend Analysis
Use this graph to draw trend lines for Taro Pharmaceutical Industries. You can use it to identify possible trend reversals for Taro Pharmaceutical as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Taro Pharmaceutical price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Taro Pharmaceutical Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Taro Pharmaceutical Industries applied against its price change over selected period. The best fit line has a slop of 0 , which means Taro Pharmaceutical Industries will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.36, which is the sum of squared deviations for the predicted Taro Pharmaceutical price change compared to its average price change.About Taro Pharmaceutical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Taro Pharmaceutical Industries on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Taro Pharmaceutical Industries based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Taro Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Taro Pharmaceutical. By analyzing Taro Pharmaceutical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Taro Pharmaceutical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Taro Pharmaceutical specific price patterns or momentum indicators. Please read more on our technical analysis page.
2020 | 2021 | 2022 | 2024 (projected) | Days Sales Outstanding | 177.45 | 199.42 | 165.3 | 104.54 | PTB Ratio | 1.65 | 0.95 | 0.53 | 3.72 |
Taro Pharmaceutical May 3, 2024 Technical Indicators
Most technical analysis of Taro help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Taro from various momentum indicators to cycle indicators. When you analyze Taro charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.02) | |||
Market Risk Adjusted Performance | (0.19) | |||
Mean Deviation | 0.3248 | |||
Coefficient Of Variation | (3,273) | |||
Standard Deviation | 0.5731 | |||
Variance | 0.3285 | |||
Information Ratio | (0.13) | |||
Jensen Alpha | (0.03) | |||
Total Risk Alpha | (0.07) | |||
Treynor Ratio | (0.20) | |||
Maximum Drawdown | 3.58 | |||
Value At Risk | (0.47) | |||
Potential Upside | 0.4986 | |||
Skewness | 0.7933 | |||
Kurtosis | 12.53 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Taro Stock analysis
When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.782 | Earnings Share 1.22 | Revenue Per Share 16.252 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0103 |
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.